Stock Scorer

Prestige Consumer Healthcare Inc. (PBH)

Prestige Consumer Healthcare Inc. reported revenue of 265.7M USD for the quarter ending 30 June 2026, up 6.5% from 249.5M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 265.7M +6.5%
Gross Profit Q2 '26 · ending 30 June 2026 136.2M -3.0%
Operating Income Q2 '26 · ending 30 June 2026 52.5M -26.8%
Net Income Q2 '26 · ending 30 June 2026 29.2M -38.5%
Cost of Revenue Q2 '26 · ending 30 June 2026 129.5M +18.6%
Operating Cash Flow Q2 '26 · ending 30 June 2026 70.8M -10.4%
Free Cash Flow Q2 '26 · ending 30 June 2026 67.1M -14.2%
Shares Outstanding Q2 '26 · ending 30 June 2026 47.6M -4.8%
EPS Q2 '26 · ending 30 June 2026 3.57 -16.4%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20262026-03-31 1.1B309.4M190.3M246.4M
20252025-03-31 1.1B336.8M214.6M243.3M
20242024-03-31 1.1B342.4M209.3M239.4M
20232023-03-31 1.1B-22.4M-82.3M221.9M
20222022-03-31 1.1B329.9M205.4M250.3M
20212021-03-31 943.4M297.4M164.7M213.4M
20202020-03-31 963M291.2M142.3M202.6M
20192019-03-31 975.8M67.5M-35.8M178.8M
20182018-03-31 1B215.5M339.6M197.6M
20172017-03-31 882.1M205.6M69.4M145.7M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q1 '272026-06-30265.7M
Q4 '262026-03-31281.6M
Q3 '262025-12-31283.4M
Q2 '262025-09-30274.1M
Q1 '262025-06-30249.5M
Q4 '252025-03-31296.5M
Q3 '252024-12-31290.3M
Q2 '252024-09-30283.8M
Q1 '252024-06-30267.1M
Q4 '242024-03-31277M
Q3 '242023-12-31282.7M
Q2 '242023-09-30286.3M
Q1 '242023-06-30279.3M
Q4 '232023-03-31285.9M
Q3 '232022-12-31275.5M
Q2 '232022-09-30289.3M
Q1 '232022-06-30277.1M
Q4 '222022-03-31266.9M
Q3 '222021-12-31274.5M
Q2 '222021-09-30276.2M

Gross Profit Quarterly

PeriodEndingGross Profit
Q1 '272026-06-30136.2M
Q4 '262026-03-31146.3M
Q3 '262025-12-31157.4M
Q2 '262025-09-30151.6M
Q1 '262025-06-30140.3M
Q4 '252025-03-31170M
Q3 '252024-12-31161M
Q2 '252024-09-30157.4M
Q1 '252024-06-30146M
Q4 '242024-03-31151.8M
Q3 '242023-12-31157.9M
Q2 '242023-09-30160M
Q1 '242023-06-30154.7M
Q4 '232023-03-31153.8M
Q3 '232022-12-31150.4M
Q2 '232022-09-30161M
Q1 '232022-06-30160.1M
Q4 '222022-03-31148.9M
Q3 '222021-12-31155.1M
Q2 '222021-09-30157.7M

Operating Income Quarterly

PeriodEndingOperating Income
Q1 '272026-06-3052.5M
Q4 '262026-03-3175.5M
Q3 '262025-12-3182.5M
Q2 '262025-09-3079.7M
Q1 '262025-06-3071.8M
Q4 '252025-03-3188.4M
Q3 '252024-12-3192M
Q2 '252024-09-3084.3M
Q1 '252024-06-3072M
Q4 '242024-03-3182.2M
Q3 '242023-12-3186.8M
Q2 '242023-09-3088.2M
Q1 '242023-06-3085.2M
Q3 '232022-12-3187.2M
Q2 '232022-09-3084.4M
Q1 '232022-06-3087M
Q4 '222022-03-3177.4M
Q3 '222021-12-3182.6M
Q2 '222021-09-3078.6M
Q1 '222021-06-3091.3M

Net Income Quarterly

PeriodEndingNet Income
Q1 '272026-06-3029.2M
Q4 '262026-03-3153.9M
Q3 '262025-12-3146.7M
Q2 '262025-09-3042.2M
Q1 '262025-06-3047.5M
Q4 '252025-03-3150.1M
Q3 '252024-12-3161M
Q2 '252024-09-3054.4M
Q1 '252024-06-3049.1M
Q4 '242024-03-3149.5M
Q3 '242023-12-3153M
Q2 '242023-09-3053.6M
Q1 '242023-06-3053.3M
Q3 '232022-12-3152M
Q2 '232022-09-3051M
Q1 '232022-06-3055.3M
Q4 '222022-03-3152.1M
Q3 '222021-12-3150.2M
Q2 '222021-09-3045.3M
Q1 '222021-06-3057.8M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q1 '272026-06-30129.5M
Q4 '262026-03-31135.3M
Q3 '262025-12-31126.1M
Q2 '262025-09-30122.5M
Q1 '262025-06-30109.2M
Q4 '252025-03-31126.5M
Q3 '252024-12-31129.3M
Q2 '252024-09-30126.4M
Q1 '252024-06-30121.1M
Q4 '242024-03-31125.2M
Q3 '242023-12-31124.8M
Q2 '242023-09-30126.3M
Q1 '242023-06-30124.6M
Q4 '232023-03-31132.1M
Q3 '232022-12-31125.1M
Q2 '232022-09-30128.3M
Q1 '232022-06-30116.9M
Q4 '222022-03-31118.1M
Q3 '222021-12-31119.4M
Q2 '222021-09-30118.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q1 '272026-06-3070.8M
Q4 '262026-03-3142.8M
Q3 '262025-12-3178.3M
Q2 '262025-09-3057.5M
Q1 '262025-06-3079M
Q4 '252025-03-3161.8M
Q3 '252024-12-3165.1M
Q2 '252024-09-3069.8M
Q1 '252024-06-3054.8M
Q4 '242024-03-3166.9M
Q3 '242023-12-3171.5M
Q2 '242023-09-3062.5M
Q1 '242023-06-3048.1M
Q4 '232023-03-3159M
Q3 '232022-12-3154.9M
Q2 '232022-09-3057.5M
Q1 '232022-06-3058.2M
Q4 '222022-03-3163.1M
Q3 '222021-12-3166.3M
Q2 '222021-09-3061.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q1 '272026-06-3067.1M
Q4 '262026-03-3137.6M
Q3 '262025-12-3175.3M
Q2 '262025-09-3055.4M
Q1 '262025-06-3078.2M
Q4 '252025-03-3158.4M
Q3 '252024-12-3163.5M
Q2 '252024-09-3067.8M
Q1 '252024-06-3053.6M
Q4 '242024-03-3163.8M
Q3 '242023-12-3169.5M
Q2 '242023-09-3059.5M
Q1 '242023-06-3046.6M
Q4 '232023-03-3156.4M
Q3 '232022-12-3153.1M
Q2 '232022-09-3055.2M
Q1 '232022-06-3057.2M
Q4 '222022-03-3160M
Q3 '222021-12-3164.1M
Q2 '222021-09-3058.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q1 '272026-06-3047.6M
Q3 '262025-12-3148.1M
Q2 '262025-09-3049.3M
Q1 '262025-06-3049.8M
Q3 '252024-12-3150M
Q2 '252024-09-3050M
Q1 '252024-06-3050.3M
Q3 '242023-12-3150.1M
Q2 '242023-09-3050.1M
Q1 '242023-06-3050.2M
Q3 '232022-12-3150.2M
Q2 '232022-09-3050.3M
Q1 '232022-06-3050.7M
Q3 '222021-12-3150.9M
Q2 '222021-09-3050.8M
Q1 '222021-06-3050.7M
Q3 '212020-12-3150.6M
Q2 '212020-09-3050.7M
Q1 '212020-06-3050.8M
Q4 '202020-03-3150.9M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q1 '272026-06-303.57
Q4 '262026-03-313.91
Q3 '262025-12-313.79
Q2 '262025-09-304.04
Q1 '262025-06-304.27
Q4 '252025-03-314.30
Q3 '252024-12-314.27
Q2 '252024-09-304.11
Q1 '252024-06-304.09
Q4 '242024-03-314.17
Q3 '232022-12-314.17
Q2 '232022-09-304.12
Q1 '232022-06-303.99
Q4 '222022-03-314.04
Q3 '222021-12-313.72
Q2 '222021-09-303.54
Q1 '222021-06-303.53
Q4 '212021-03-313.25
Q3 '212020-12-313.28
Q2 '212020-09-303.22